Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia

Exclusion Criteria

• •Acute bleeding \> 500 mL within 72 hours
• •Anaemia predominantly caused by factors other than IDA
• •Hemochromatosis or other iron storage disorders
• •Previous serious hypersensitivity reactions to any IV iron compounds
• •Treatment with IV iron within the last 30 days prior to screening
• •Treatment with erythropoietin or erythropoietin-stimulation agents
• •Red blood cell transfusion, radiotherapy, and/or chemotherapy
• •Received an investigational drug within the last 30 days prior to screening
• •Planned surgical procedure within the trial period
• •Hepatic enzymes \> 3 times upper limit of normal
• •Surgery under anaesthetic within the last 30 days prior to screening
• •Any non-viral infection within the last 30 days prior to screening
• •Alcohol or drug abuse within the past 6 months
• •Vitamin D deficiency
• •Untreated hyperparathyroidism
• •Kidney transplantation
• •Active malignant disease, disease-free for less than 5 years
• •History of a psychological illness or seizures
• •Pregnant or nursing women.